Evidence map›Paper›PMID 27879349›Full record

ReviewASN neuro2016

NCAM1 Polysialylation: The Prion Protein's Elusive Reason for Being?

Mohadeseh Mehrabian, Herbert Hildebrandt, Gerold Schmitt-Ulms

Open access · goldAbstract readReview
In one paragraph

Review in ASN neuro, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Post-translational modifications in prion diseases.Frontiers in molecular neuroscience · 2024
    Review
  5. Review
  6. Evidence for the Benefits of Melatonin in Cardiovascular Disease.Frontiers in cardiovascular medicine · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Mechanism ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Mohadeseh MehrabianTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
Herbert HildebrandtInstitute for Cellular Chemistry, Hannover Medical School, Hannover, Germany.
Gerold Schmitt-UlmsTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada g.schmittulms@utoronto.ca.
Occupational Cancer Research Centre · CAMedizinische Hochschule Hannover · DE

Funding

CIHR
6 · The paper itself

Abstract

Much confusion surrounds the physiological function of the cellular prion protein (PrP

Indexed as

AnimalsCD56 AntigenHumansNeurogenesisPrion ProteinsProtein Interaction MapsSialic AcidsSialyltransferasesSignal TransductionCD56 AntigenCMP-N-acetylneuraminate-poly-alpha-2,8-sialosyl sialyltransferaseNCAM1 protein, humanpolysialic acidPrion ProteinsSialic AcidsSialyltransferasesneural cell adhesion moleculespolysialic acidpolysialyltransferasesprion proteinprotein functionsignaling

Identifiers

PMID27879349
PMCPMC5122176
OpenAlexW2554998288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.